Satellos Bioscience Inc.

Biotechnology • Healthcare • Toronto, ON, United States • MSCLF (OQB)

Satellos Bioscience Inc., a biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia. The company uses its proprietary platform MyoReGenX, an automated microscopy system that recapitulates the muscle stem cell environment ex-vivo. It develops SAT-3247 an oral, small-molecule drug candidate for the treatment of Duchenne muscular dystrophy disease. The company has a license agreement the with Ottawa Hospital Research Institute (OHRI); and an option agreement with the University of British Columbia. Satellos Bioscience Inc. was founded in 2018 and is headquartered in Toronto, Canada.

Stock Performance (90 Days)

Data through Dec 24, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Satellos Bioscience Inc. had layoffs?

No layoff events have been recorded for Satellos Bioscience Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Satellos Bioscience Inc. have?

Satellos Bioscience Inc. has approximately 14 employees.

What industry is Satellos Bioscience Inc. in?

Satellos Bioscience Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Satellos Bioscience Inc. a publicly traded company?

Yes, Satellos Bioscience Inc. is publicly traded under the ticker symbol MSCLF on the OQB. The company has a market capitalization of approximately $0.09 billion.

Where is Satellos Bioscience Inc. headquartered?

Satellos Bioscience Inc. is headquartered in Toronto, ON, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.